Skip to content
Governance Register

← US public companies

Lieber Jonathan I

SEC-identified person · CIK 1350090 Identifier-verified

Public-company roles (from insider filings)

CompanyCapacity as filedFilings
Rallybio Corp RLYB See Remarks filed 2023–2026
Salarius Pharmaceuticals, Inc. SLRX Director filed 2020–2024
Applied Genetic Technologies Corp AGTC Chief Financial Officer filed 2021–2022
Checkmate Pharmaceuticals, Inc. CMPI See Remarks filed 2020–2020
Ocugen, Inc. OCGN Chief Financial Officer filed 2015–2018
Repligen Corp RPGN CFO filed 2012–2013
Altus Pharmaceuticals Inc. ALTU VP, CFO and Treasurer filed 2006–2008

All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.